News

April 24, 2014

Not intended for U.S. and UK Media

Positive Results from Phase III DECISION Study of Sorafenib in RAI-Refractory Differentiated Thyroid Cancer Published in The Lancet
Sorafenib significantly extended progression-free survival compared to placebo in patients with differentiated thyroid carcinoma (DTC) that is refractory to radioactive iodine treatment (RAI-refractory) / Based on study results, Nexavar is approved in U.S. for RAI-refractory DTC; filing has also been submitted in EU more

April 23, 2014

Not intended for U.S. and UK Media

Bayer Submits Riociguat for the Treatment of Pulmonary Arterial Hypertension in Japan more

April 22, 2014

Not intended for U.S. and UK Media - Non-Cystic Fibrosis Bronchiectasis (NCFB)

FDA Grants Orphan Drug Designation for Bayer’s Investigational Ciprofloxacin Dry Powder for Inhalation for Treatment of NCFB more

News Overview

Videos

Video Overview

Facebook

Bayer@Facebook

Bayer Today starts the World Immunization Week. Vaccination cannot only save lives but also eradicate diseases such as polio or measles. We support the World Health Organization's Immunization Week to raise your awareness of this important issue.

Learn more
http://www.who.int/campaigns/immunization-week/2014/en/

April 24, 2014

Bayer

April 23, 2014

Twitter

Follow Bayer on Twitter

Bayer #NobelPrize Gerhard Domagk discovered 1st drug against bacterial infections.Scientist of Bayer http://t.co/GS6WB3TxK8 http://t.co/Yx2nJaY2mVApril 24, 2014

Bayer svlzx we value your opinion and will forward your remark to our colleagues.April 24, 2014

Social Media Overview

Publications

Integrated Annual Report 2013

Continuous growth in Bayer’s Anniversary Year

more

Overview Annual Reports

Apps

Bayer magazine

The new edition of the Bayer magazine takes you on a multimedia discovery tour! Read fascinating stories about the things that are happening now in the world of Bayer.

more

Apps Overview